Group One Trading’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Group One Trading’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,600	Closed	-$150K	–	8608
2024 Q4	$150K	Buy	+15,600	New	+$81.4K	﹤0.01%	4173
2024 Q3	–	Sell	-2,500	Closed	-$7.3K	–	7533
2024 Q2	$7.3K	Hold	2,500	–	–	﹤0.01%	5780
2024 Q1	$7.97K	Buy	+2,500	New	+$8.34K	﹤0.01%	5986
2023 Q4	–	Sell	-2,300	Closed	-$5.47K	–	8355
2023 Q3	$5.47K	Buy	2,300 +300	+15%	+$629	﹤0.01%	6656
2023 Q2	$3.52K	Buy	2,000 +700	+54%	+$1.79K	﹤0.01%	6872
2023 Q1	$4K	Buy	1,300 +200	+18%	+$1.2K	﹤0.01%	6376
2022 Q4	$5.83K	Buy	+1,100	New	+$5.03K	﹤0.01%	6270

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Group One Trading's PSTX Position: Q1 2025 in Review

Group One Trading sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 5,235 shares — an estimated $50.3K sold.

Group One Trading first reported a position in PSTX in Q3 2022 and held it in 6 quarters. The position peaked at $50.3K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

Group One Trading reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Group One Trading sold 5,235 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $50.3K.
Group One Trading first reported a position in Poseida Therapeutics, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
Group One Trading's Poseida Therapeutics, Inc. Common Stock position peaked at $50.3K in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.